Norges Bank’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,029,913
| Closed | -$89.9M | – | 577 |
|
|
2025
Q4 | $89.9M | Buy |
+1,029,913
| New | +$78.2M | 0.01% | 801 |
|
|
2025
Q3 | – | Sell |
-1,152,793
| Closed | -$68M | – | 645 |
|
|
2025
Q2 | $68M | Buy |
1,152,793
+27,785
| +2% | +$1.8M | 0.01% | 835 |
|
|
2025
Q1 | $82.4M | Sell |
1,125,008
-290,805
| -21% | -$24M | 0.01% | 753 |
|
|
2024
Q4 | $117M | Sell |
1,415,813
-409,517
| -22% | -$32.3M | 0.02% | 622 |
|
|
2024
Q3 | $131M | Buy |
1,825,330
+19,528
| +1% | +$1.38M | 0.02% | 589 |
|
|
2024
Q2 | $124M | Sell |
1,805,802
-143,411
| -7% | -$8.57M | 0.02% | 568 |
|
|
2024
Q1 | $105M | Buy |
1,949,213
+156,429
| +9% | +$8.41M | 0.02% | 633 |
|
|
2023
Q4 | $95.5M | Buy |
1,792,784
+836,272
| +87% | +$40.8M | 0.02% | 617 |
|
|
2023
Q3 | $47.5M | Buy |
956,512
+173,102
| +22% | +$9.68M | 0.01% | 863 |
|
|
2023
Q2 | $46.6M | Sell |
783,410
-25,063
| -3% | -$1.43M | 0.01% | 886 |
|
|
2023
Q1 | $45.8M | Buy |
808,473
+656,073
| +430% | +$42.1M | 0.01% | 870 |
|
|
2022
Q4 | $11.3M | Buy |
152,400
+41,103
| +37% | +$2.8M | ﹤0.01% | 1527 |
|
|
2022
Q3 | $6.63M | Buy |
111,297
+5,017
| +5% | +$302K | ﹤0.01% | 1672 |
|
|
2022
Q2 | $5.97M | Sell |
106,280
-5,930
| -5% | -$390K | ﹤0.01% | 1727 |
|
|
2022
Q1 | $8.28M | Sell |
112,210
-559,503
| -83% | -$38.9M | ﹤0.01% | 1762 |
|
|
2021
Q4 | $48.5M | Buy |
671,713
+84,456
| +14% | +$6.13M | 0.01% | 951 |
|
|
2021
Q3 | $45M | Hold |
587,257
| – | – | 0.01% | 976 |
|
|
2021
Q2 | $45.5M | Sell |
587,257
-27,042
| -4% | -$1.92M | 0.01% | 1021 |
|
|
2021
Q1 | $37.9M | Sell |
614,299
-104,418
| -15% | -$6.61M | 0.01% | 1136 |
|
|
2020
Q4 | $46.9M | Sell |
718,717
-115,277
| -14% | -$6.63M | 0.01% | 1018 |
|
|
2020
Q3 | $41.3M | Sell |
833,994
-126,415
| -13% | -$6.52M | 0.01% | 943 |
|
|
2020
Q2 | $45.8M | Sell |
960,409
-45,511
| -5% | -$2.2M | 0.01% | 891 |
|
|
2020
Q1 | $42.8M | Sell |
1,005,920
-7,015
| -0.7% | -$347K | 0.02% | 778 |
|
|
2019
Q4 | $59.6M | Hold |
1,012,935
| – | – | 0.02% | 796 |
|
|
2019
Q3 | $51.8M | Hold |
1,012,935
| – | – | 0.02% | 847 |
|
|
2019
Q2 | $42.8M | Hold |
1,012,935
| – | – | 0.01% | 967 |
|
|
2019
Q1 | $50M | Hold |
1,012,935
| – | – | 0.02% | 870 |
|
|
2018
Q4 | $43.8M | Hold |
1,012,935
| – | – | 0.02% | 836 |
|
|
2018
Q3 | $57.5M | Hold |
1,012,935
| – | – | 0.02% | 763 |
|
|
2018
Q2 | $51.1M | Hold |
1,012,935
| – | – | 0.02% | 817 |
|
|
2018
Q1 | $50.5M | Buy |
1,012,935
+49,140
| +5% | +$2.31M | 0.02% | 785 |
|
|
2017
Q4 | $39.6M | Sell |
963,795
-71,356
| -7% | -$2.5M | 0.01% | 953 |
|
|
2017
Q3 | $30.8M | Buy |
1,035,151
+119,318
| +13% | +$3.64M | 0.01% | 1138 |
|
|
2017
Q2 | $30.4M | Sell |
915,833
-28,723
| -3% | -$902K | 0.01% | 1105 |
|
|
2017
Q1 | $28M | Buy |
944,556
+206,115
| +28% | +$5.63M | 0.01% | 1148 |
|
|
2016
Q4 | $18.3M | Buy |
738,441
+235,882
| +47% | +$5.36M | 0.01% | 1377 |
|
|
2016
Q3 | $10.8M | Sell |
502,559
-155,040
| -24% | -$3.64M | 0.01% | 1606 |
|
|
2016
Q2 | $15.7M | Sell |
657,599
-50,000
| -7% | -$1.2M | 0.01% | 1357 |
|
|
2016
Q1 | $16.8M | Hold |
707,599
| – | – | 0.01% | 1268 |
|
|
2015
Q4 | $19.7M | Hold |
707,599
| – | – | 0.01% | 1170 |
|
|
2015
Q3 | $14.6M | Sell |
707,599
-27,400
| -4% | -$694K | 0.01% | 1324 |
|
|
2015
Q2 | $18.9M | Hold |
734,999
| – | – | 0.01% | 1231 |
|
|
2015
Q1 | $18.6M | Sell |
734,999
-169,160
| -19% | -$4.12M | 0.01% | 1256 |
|
|
2014
Q4 | $21.5M | Hold |
904,159
| – | – | 0.01% | 1156 |
|
|
2014
Q3 | $17.8M | Sell |
904,159
-390,021
| -30% | -$8.02M | 0.01% | 1214 |
|
|
2014
Q2 | $31M | Buy |
+1,294,180
| New | +$31.2M | 0.01% | 1335 |
|
Other funds holding GMED
VCM
VPM
SC
Norges Bank's GMED Position: Q1 2026 in Review
Norges Bank sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 1,029,913 shares — an estimated $89.9M sold.
Norges Bank first reported a position in GMED in Q2 2014 and held it in 46 quarters. The position peaked at $131M in Q3 2024. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.
- Norges Bank reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
- Norges Bank sold 1,029,913 Globus Medical shares in Q1 2026, an estimated $89.9M.
- Norges Bank first reported a position in Globus Medical in Q2 2014 and held it in 46 quarters.
- Norges Bank's Globus Medical position peaked at $131M in Q3 2024.
- 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.
Based on Norges Bank's 13F filing for Q1 2026.